Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Johnson

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
Journal of Neurosurgery|April 23, 2016
Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter studyOr Cohen-Inbar, Cheng-Chia Lee, Seyed H Mousavi, et al.
NPJ Digital Medicine|July 16, 2019
Highly flexible, wearable, and disposable cardiac biosensors for remote and ambulatory monitoringStephen P Lee, Grace Ha, Don E Wright, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Heterobiaryl purine derivatives as potent antiproliferative agents: inhibitors of cyclin dependent kinases. Part IIMichael P Trova, Keith D Barnes, Luis Alicea, et al.
Cell Reports|August 30, 2018
Pathogenic TFG Mutations Underlying Hereditary Spastic Paraplegia Impair Secretory Protein Trafficking and Axon FasciculationErin L Slosarek, Amber L Schuh, Iryna Pustova, et al.
Nature Communications|December 1, 2023
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8Dawei Sun, Yonglian Sun, Eric Janezic, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Haploinsufficiency of lysosomal enzyme genes in Alzheimer's diseaseBruno A Benitez, Clare E Wallace, Maulikkumar Patel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMark Sands, Bruno A Benitez, Clare E Wallace, et al.
Nature Communications|July 1, 2021
RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric siteKatarzyna Z Haza, Heather L Martin, Ajinkya Rao, et al.
Cancers|April 3, 2021
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II StudyChristine H Chung, Marcelo Bonomi, Conor E Steuer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaChristine H Chung, Jiannong Li, Conor E Steuer, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Journal of Neurosurgery|April 23, 2016
Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter studyOr Cohen-Inbar, Cheng-Chia Lee, Seyed H Mousavi, et al.
NPJ Digital Medicine|July 16, 2019
Highly flexible, wearable, and disposable cardiac biosensors for remote and ambulatory monitoringStephen P Lee, Grace Ha, Don E Wright, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Heterobiaryl purine derivatives as potent antiproliferative agents: inhibitors of cyclin dependent kinases. Part IIMichael P Trova, Keith D Barnes, Luis Alicea, et al.
Cell Reports|August 30, 2018
Pathogenic TFG Mutations Underlying Hereditary Spastic Paraplegia Impair Secretory Protein Trafficking and Axon FasciculationErin L Slosarek, Amber L Schuh, Iryna Pustova, et al.
Nature Communications|December 1, 2023
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8Dawei Sun, Yonglian Sun, Eric Janezic, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Haploinsufficiency of lysosomal enzyme genes in Alzheimer's diseaseBruno A Benitez, Clare E Wallace, Maulikkumar Patel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMark Sands, Bruno A Benitez, Clare E Wallace, et al.
Nature Communications|July 1, 2021
RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric siteKatarzyna Z Haza, Heather L Martin, Ajinkya Rao, et al.
Cancers|April 3, 2021
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II StudyChristine H Chung, Marcelo Bonomi, Conor E Steuer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaChristine H Chung, Jiannong Li, Conor E Steuer, et al.
Pageof 30